Evidence map›Paper›PMID 29390050›Full record

ArticleBrain : a journal of neurology2018

A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy.

Juliette Piard, George K Essien Umanah, Frederike L Harms, Leire Abalde-Atristain, Daniel Amram, Melissa Chang, Rong Chen, Malik Alawi, Vincenzo Salpietro, Mark I Rees and 7 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Cryo-EM structure of AAA + ATPase thorase reveals novel helical filament formation.Computational and structural biotechnology journal · 2025
    Article
  5. Article
  6. Mitohormesis.Cell metabolism · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Biallelic Variants inInternational journal of molecular sciences · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Juliette PiardCentre de génétique humaine, Université de Franche-Comté, Besançon, France.
George K Essien UmanahNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Frederike L HarmsInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Leire Abalde-AtristainNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Daniel AmramUnité fonctionnelle de génétique clinique, Centre hospitalier intercommunal, Créteil, France.
Melissa ChangNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Rong ChenNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Malik AlawiUniversity Medical Center Hamburg-Eppendorf, Bioinformatics Core Facility, 20246 Hamburg, Germany.
Vincenzo SalpietroDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Mark I ReesNeurology Research Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, UK.
Seo-Kyung ChungNeurology Research Group, Institute of Life Science, Swansea University Medical School, Swansea University, Swansea, UK.
Henry HouldenDepartment of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
Alain VerloesDepartment of Genetics, Robert-Debré Hospital, Paris, France.
Ted M DawsonNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Valina L DawsonNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Lionel Van MaldergemCentre de génétique humaine, Université de Franche-Comté, Besançon, France.
Kerstin KutscheInstitute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Funding

UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.P50DA000266 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SNYDER, SOLOMON H. · 1985 to 2017
$45.2M
Training Program in Cellular and Molecular MedicineT32GM008752 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI RAO, RAJINI · 2000 to 2019
$11.7M
Determination of the mechanism underlying Thorase modulation of AMPARs mediated neurotransmissionK01NS099362 · NINDS · JOHNS HOPKINS UNIVERSITY · PI UMANAH, GEORGE KWABENA ESSIEN · 2017 to 2019
$689k
NIDA NIH HHS P50 DA000266NIGMS NIH HHS T32 GM008752NINDS NIH HHS K01 NS099362
6 · The paper itself

Abstract

Members of the AAA+ superfamily of ATPases are involved in the unfolding of proteins and disassembly of protein complexes and aggregates. ATAD1 encoding the ATPase family, AAA+ domain containing 1-protein Thorase plays an important role in the function and integrity of mitochondria and peroxisomes. Postsynaptically, Thorase controls the internalization of excitatory, glutamatergic AMPA receptors by disassembling complexes between the AMPA receptor-binding protein, GRIP1, and the AMPA receptor subunit GluA2. Using whole-exome sequencing, we identified a homozygous frameshift mutation in the last exon of ATAD1 [c.1070_1071delAT; p.(His357Argfs*15)] in three siblings who presented with a severe, lethal encephalopathy associated with stiffness and arthrogryposis. Biochemical and cellular analyses show that the C-terminal end of Thorase mutant gained a novel function that strongly impacts its oligomeric state, reduces stability or expression of a set of Golgi, peroxisomal and mitochondrial proteins and affects disassembly of GluA2 and Thorase oligomer complexes. Atad1-/- neurons expressing Thorase mutantHis357Argfs*15 display reduced amount of GluA2 at the cell surface suggesting that the Thorase mutant may inhibit the recycling back and/or reinsertion of AMPA receptors to the plasma membrane. Taken together, our molecular and functional analyses identify an activating ATAD1 mutation as a new cause of severe encephalopathy and congenital stiffness.

Indexed as

Adenosine TriphosphatasesATPases Associated with Diverse Cellular ActivitiesBrain DiseasesCarrier ProteinsDNA Mutational AnalysisFamily HealthFemaleGene Expression RegulationHomozygoteHumansInfantMagnetic Resonance ImagingMaleMitochondriaModels, MolecularMultiprotein ComplexesAdenosine TriphosphatasesATAD1 protein, humanATPases Associated with Diverse Cellular ActivitiesCarrier Proteinsglutamate receptor ionotropic, AMPA 2GRIP1 protein, humanMultiprotein ComplexesNerve Tissue ProteinsReceptors, AMPARNA, Messenger

Identifiers

PMID29390050
PMCPMC5837721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.